Status:
UNKNOWN
Alzheimer's Disease, Art and Garden
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Alzheimer Disease
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Gardens and art represent public spaces and support venues of interactions and emotions, seeking not only a variety of conversational themes but also various cognitive skills such as mnemonic skills. ...
Detailed Description
RESEARCH METHODOLOGY / EXPERIMENTAL DESIGN Open, monocentric, controlled (group of healthy control subjects) study. Population: 2 groups: Group A "Alzheimer group": patients with mild to severe sta...
Eligibility Criteria
Inclusion
- aged 60 to 100 years
- able to walk independently, that is to say without recourse to aid, whether human or technical, except for a simple cane
- have never been in the garden " art, memory and life " of the Paul Spillmann Centre
- gave their written consent after receiving clear and intelligible written and oral information
- with a diagnosis of a probable mild to severe stage of Alzheimer's disease according to NINCDS-ADRDA diagnostic criteria (McKhann et al., 1984) within the last 2 months prior to inclusion
- score less than or equal to 4 on the Hachinski Ischemic Scale (Hachinski et al., 1984) within the last 2 months prior to inclusion
- Folstein MMSE score between 7 and 24 inclusively within the last 2 months prior to inclusion
- score of 4, 5 or 6 on the Reisberg Global Deterioration Scale (Reisberg et al., 1982) within a 2-month delay prior to inclusion
- specific drug treatment for Alzheimer's disease, unchanged since at least 2 months (cholinesterase inhibitor and memantine)
- no change in psychotropic treatment within 48 hours prior to inclusion
Exclusion
- lack of insurance coverage
- sensory deficit interfering with the designated tasks in the study
- phasic disorders interfering with the designated tasks in the study
- history of head trauma (with loss of consciousness)
- chronic alcoholism
- refusal or inability to obtain the informed written consent of the subject
- persons subject to a legal protection order
- severe depression: score \> 20 on the GDS (Geriatric Depression Scale) scale at inclusion
- other neurological or psychiatric disorders potentially affecting the assessment
- current or planned participation to other research involving neuropsychological evaluations and/or drug trial, up until the end of the current study
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02208193
Start Date
July 1 2014
End Date
September 1 2017
Last Update
July 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Nancy
Nancy, France, 54000